Evidence map›Paper›PMID 35780086›Full record

ReviewBMC pregnancy and childbirth2022

Diffuse myometrium thinning and placenta accreta spectrum in a patient with systemic lupus erythematosus (SLE): a case report and review of the literature.

Tomohiro Mitoma, Kei Hayata, Satomi Yokohata, Akiko Ohira, Chiaki Kashino, Satoe Kirino, Kazumasa Tani, Jota Maki, Eriko Eto, Hisashi Masuyama

Abstract readCase ReportsReview
In one paragraph

Review in BMC pregnancy and childbirth, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tomohiro MitomaDepartment of Obstetrics and Gynecology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Department of Obstetrics and Gynecology, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama city, Okayama, 700-8558, Japan. tomohiro.mitoma@gmail.com.ORCID http://orcid.org/0000-0001-8013-0718
Kei HayataDepartment of Obstetrics and Gynecology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Department of Obstetrics and Gynecology, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama city, Okayama, 700-8558, Japan.
Satomi YokohataDepartment of Obstetrics and Gynecology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Department of Obstetrics and Gynecology, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama city, Okayama, 700-8558, Japan.
Akiko OhiraDepartment of Obstetrics and Gynecology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Department of Obstetrics and Gynecology, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama city, Okayama, 700-8558, Japan.
Chiaki KashinoDepartment of Obstetrics and Gynecology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Department of Obstetrics and Gynecology, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama city, Okayama, 700-8558, Japan.
Satoe KirinoDepartment of Obstetrics and Gynecology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Department of Obstetrics and Gynecology, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama city, Okayama, 700-8558, Japan.
Kazumasa TaniDepartment of Obstetrics and Gynecology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Department of Obstetrics and Gynecology, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama city, Okayama, 700-8558, Japan.
Jota MakiDepartment of Obstetrics and Gynecology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Department of Obstetrics and Gynecology, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama city, Okayama, 700-8558, Japan.
Eriko EtoDepartment of Obstetrics and Gynecology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Department of Obstetrics and Gynecology, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama city, Okayama, 700-8558, Japan.
Hisashi MasuyamaDepartment of Obstetrics and Gynecology, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Department of Obstetrics and Gynecology, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama city, Okayama, 700-8558, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCases of uterine wall thinning and placental abnormalities complicated with systemic lupus erythematosus (SLE) during pregnancy have been reported in Asian countries for ten years. Long-term steroid use can cause muscle degeneration, but the mechanism of myometrium thinning was not known. Through the review of published articles, this report is the first review of cases to discuss the pathogenesis and clinical features of thinned myometrium and placenta accreta spectrum (PAS) in pregnant patients with SLE. CASE PRESENTATION: A twenty-nine-year-old primigravida with a history of lupus enteritis and paralytic ileus had a natural conception after less than two years of steroid treatment. An ultrasonographic study showed a thin uterine wall with a widespread thick placenta on the entire surface of the uterine cavity in the third trimester. At the 39th gestational week, she underwent a cesarean section due to the failure of the uterus to contract, even though the injection of oxytocin. There were several engorged vessels on the surface of the anterior uterine wall at the time of laparotomy. We decided to perform a hysterectomy because diffuse PAS replaced her uterus.

conclusionA review of reported cases and our case shows an unusual complication of SLE that might be related to the particular condition of the estrogen-mediated immune system. Clinicians should always pay attention to the possibility of uterine wall thinning as uterine atony and the structural abnormality of the placenta for SLE patients with the unscarred uterus.

Indexed as

Lupus Erythematosus, SystemicPlacenta AccretaAdultCesarean SectionFemaleHumansMyometriumPlacentaPregnancySteroidsSteroidsEstrogenLupusMyometriumPlacenta accreta spectrumUterine atony

Identifiers

PMID35780086
PMCPMC9250175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.